US 12,376,989 B2
Drug eluting ocular implants and methods of treating an ocular disorder
David S. Haffner, Mission Viejo, CA (US); Kenneth M. Curry, Oceanside, CA (US); Harold A. Heitzmann, Irvine, CA (US); and David Applegate, Laguna Hills, CA (US)
Assigned to Glaukos Corporation, Aliso Viejo, CA (US)
Filed by Glaukos Corporation, Aliso Viejo, CA (US)
Filed on Dec. 13, 2024, as Appl. No. 18/980,347.
Application 18/980,347 is a continuation of application No. 17/219,102, filed on Mar. 31, 2021, granted, now 12,201,555.
Application 17/219,102 is a continuation of application No. 15/422,384, filed on Feb. 1, 2017, abandoned.
Application 15/422,384 is a continuation of application No. 13/321,144, abandoned, previously published as PCT/US2010/035319, filed on May 18, 2010.
Claims priority of provisional application 61/264,594, filed on Nov. 25, 2009.
Claims priority of provisional application 61/264,604, filed on Nov. 25, 2009.
Claims priority of provisional application 61/264,615, filed on Nov. 25, 2009.
Claims priority of provisional application 61/220,527, filed on Jun. 25, 2009.
Claims priority of provisional application 61/179,332, filed on May 18, 2009.
Prior Publication US 2025/0107928 A1, Apr. 3, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 9/007 (2006.01); A61F 9/00 (2006.01); A61K 9/00 (2006.01)
CPC A61F 9/0017 (2013.01) [A61F 9/00781 (2013.01); A61K 9/0051 (2013.01); A61F 2210/0004 (2013.01); A61F 2250/0068 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A method of implanting a drug delivery ocular implant, the method comprising:
inserting a delivery instrument releasably holding a drug delivery implant into an anterior chamber of an eye, the drug delivery implant having travoprost stored within a reservoir of the drug delivery implant;
advancing the delivery instrument through the anterior chamber of the eye towards a trabecular meshwork;
using the delivery instrument, affixing an anchor into scleral tissue, wherein a first end of the drug delivery implant configured to elute the travoprost is positioned within the anterior chamber of the eye;
releasing the drug delivery implant from the delivery instrument; and
removing the delivery instrument from the eye.